Regulatory Know-How for Development & Growth-Stage Life Sciences Innovators

Please join Sidley’s Global Life Sciences team to lean into key early-stage and emerging growth regulatory issues, and how to tackle them.

Sessions will focus on:

• All phases of clinical research and development
• Press releases and disclosures
• Regulatory wisdom from experienced emerging growth General Counsels

Connect with industry peers and investors during networking breaks and a post-program cocktail hour.

This program is designed for legal professionals and executives to provide a foundation in FDA, healthcare, and securities issues arising in development stage companies.

Featured Speakers

• Himani Bhalla, Senior Managing Director, Chief Investment Officer, and Co-Founder, Symbiotic Capital
• Greg Bowman, Senior Director, Leasing, Breakthrough Properties
• Michael Brown, Executive Vice President and Chief, Legal Officer, DexCom, Inc.
• Aneta Ferguson, Senior Vice President and General Counsel, Adverum Biotechnologies
• Michael Mueller, General Counsel, Sidewinder Therapeutics, Inc.

Meet Members of the Sidley Team

• Torey Cope, Food, Drug, and Medical Device Regulatory
• Meenakshi Datta, Healthcare: Drug and Medical Device Regulatory
• Sharon Flanagan, M&A, Capital Markets, Corporate Governance
• Carlton Fleming, Capital Markets
• Cindy Lovering, Global Finance
• James Lu, Emerging Companies and Venture Capital
• Jon Olsen, M&A, Emerging Companies and Venture Capital
• Adam Welland, Technology and Life Sciences Transactions

Agenda

1:00 p.m.: Registration
1:30 – 4:30 p.m.:

1. Clinical Research Challenges and Opportunities
2. Key Considerations for Press Releases and SEC Disclosures
3. Fireside Chat: The Importance of Regulatory Strategy and Compliance from Seasoned Emerging Growth GCs and In-House Counsel

4:30 – 6:30 p.m.: Cocktail Reception

CLE credit for this program is pending.